# Use of Bayesian Methodology in Clinical Trials of Drug and Biological Products: Draft Guidance for Industry - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/use-of-bayesian-methodology-in-clinical-trials-of-drug-and-biological-products-draft-guidance-for-industry/8e9c345e-0994-47b3-8d6c-054f04ed937e

> FDA guidance document: Use of Bayesian Methodology in Clinical Trials of Drug and Biological Products: Draft Guidance for Industry. Issue date: January 09, 2026. Get complete insights and analysis.

---

## Details

- Title: Use of Bayesian Methodology in Clinical Trials of Drug and Biological Products: Draft Guidance for Industry
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2026-01-09
- Last Changed: 2026-01-12
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2025-D-3217">FDA-2025-D-3217</a>

## Related Documents

- [Master Protocols for Drug and Biological Product Development](https://www.globalkeysolutions.net/guidances/guidance-document/master-protocols-for-drug-and-biological-product-development/401e65ec-7388-4389-a95a-dc8860a1ce51)
- [Meta-Analyses of Randomized Controlled Clinical Trials to Evaluate the Safety of Human Drugs or Biological Products](https://www.globalkeysolutions.net/guidances/guidance-document/meta-analyses-of-randomized-controlled-clinical-trials-to-evaluate-the-safety-of-human-drugs-or-biological-products/0ed49ff3-89c9-4436-8c06-0324d3e2aff2)
- [Nonproprietary Naming of Biological Products: Update Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/nonproprietary-naming-of-biological-products-update-guidance-for-industry/8adaef5a-6903-4e65-ac57-121d51429730)